ASN 2010 USRDS Presentations

Archives: 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2016

USRDS Special Sessions

Overview of the ESRD program: Infectious Complications and Catheters

CKD & outcomes in the general population: Which Test, Which Formula?

Predialysis Education and Incident Patients' Modality Choice and Transplant Wait Listing:Findings from the CDS

Medication Trends in Dialysis Patients—Focus on Medicare Part D

Trends in Medication Use after Kidney Transplant

Acute kidney injury –Influence of race; Outcomes of AKI

Free Communication Sessions

Association between Early Acute Rejection and All-Cause Kidney Allograft Failure Has Increased While the Incidence of AR Has Decreased over a Recent Decade in the US.

Continued use of Transfusion in the Transplant Waitlist Population, Even Among Non-Sensitized Candidates.

Increasing Use of "Riskier" Deceased Kidney Donors in the US in the Past Decade.

CKD, Metabolic Abnormalities and Outcomes in US Adults < 65: CKD-EPI or MDRD Formulas?

Cardiovascular Medication Use in Kidney Transplant Recipients

Posters

Frequency of nephrologist claims prior to ESRD initiation, by CKD stage

Medicare Part D enrollment & medication use & costs in US dialysis patients in 2007

Use & costs of antidiabeticmedications in U.S. adult dialysis patients with Medicare Part D in 2007

Use and costs of phosphate binders in U.S. dialysis patients with Medicare Part D in 2007

A comparison of cost distribution during the transition to ESRD in the US & Taiwan

Racial disparity in hospital admissions for vascular access infection among incident hemodialysis patients

Racial disparity in mortality, by identified CKD stages in elderly Medicare patients

Sources of drug coverage among Medicare beneficiaries with end-stage renal disease

A comparison of comorbidity in CKD patients based on MDRD vs. CKD-EPI equations

CystatinC, mortality risk, & clinical triage in US adults: threshold values & hierarchical importance

Pre-dialysis dietitian care & survival during the first year on dialysis

Use and costs of ACEIs, ARBs, and ReninInhibitorsin U.S. adult dialysis patients with Medicare Part D in 2007

Discriminators of death and survival in the first year of hemodialysis: Threshold Values and hierarchical importance –The United States Renal Data System

Mortality patterns & day of the week: the United States Renal Data System (USRDS)

UNITED STATES RENAL DATA SYSTEM